Sequent Scientific Limited (NSE:SEQUENT)

Market Cap	48.20B
Revenue (ttm)	15.51B
Net Income (ttm)	218.80M
Shares Out	n/a
EPS (ttm)	0.85
PE Ratio	220.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	305,477
Average Volume	683,493
Open	192.75
Previous Close	192.75
Day's Range	185.85 - 193.60
52-Week Range	116.80 - 240.70
Beta	1.12
RSI	49.45
Earnings Date	May 21, 2025

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology fo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,195
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SEQUENT